7Kumagai K, Takagi T, Nakamura S, et al. Hepatitis B virus carriers in the treatment of malignant lymphoma: an epidemiological study in Japan [J]. Ann Oncol, 1997,8(suppl1 ): 107-109.
8Nakamura Y, Motokura T, Fujita A, et al. Severe hepatitis related to chemotherapy in hepatitis B carriers with hematological malignancies [ J ]. Cancer, 1996,78 (10): 2210-2215.
9Liang RH, Lok AS, Lai CL, et al. Hepatitis B infection in patients with lymphomas [J]. Hematol Oncol, 1990,8(5):261-270.
10Yeo W, Chan PK, Zhong S, et al. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors [J]. J Med Virol, 2000,62(3):299-307.
10Miao-Zhen Qiu1,2, Dan-Yun Ruan1,2, Zhi-Qiang Wang1,2, Hui-Yan Luo1,2, Kai-Yuan Teng1,2, Zhong-Jun Xia1,3, Yue Lu1,3, Hui-Qiang Huang1,2, Wen-Qi Jiang1,2, Rui-Hua Xu1,2 1 State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P. R. China,2 Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P. R. China,3 Department of Hematology Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P. R. China.Expression of hepatitis B virus surface antigen in 120 Hodgkin's lymphoma patients[J].Chinese Journal of Cancer,2010,29(8):735-740. 被引量：7
